bispecific antibody therapeutics (Zymeworks/Bristol-Myers Squibb)
N/A
Report date: 2025/01/26 17:45:55
Base Information
Drug Namebispecific antibody therapeutics (Zymeworks/Bristol-Myers Squibb)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZymeworks Inc
China Registration ClassN/A
Develop Information
Active CompaniesZymeworks IncBristol-Myers Squibb Company
Inactive CompaniesCelgene Corp
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A